161 related articles for article (PubMed ID: 31186263)
21. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
[TBL] [Abstract][Full Text] [Related]
22. Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease.
Yu C; Xue H; Wang L; Chen Q; Chen X; Zhang Y; Hu G; Ling W
Circ Res; 2018 Sep; 123(8):996-1007. PubMed ID: 30355032
[TBL] [Abstract][Full Text] [Related]
23. Association of Circulating 25-Hydroxyvitamin D Levels with Colorectal Cancer: An Updated Meta-Analysis.
Xu J; Yuan X; Tao J; Yu N; Wu R; Zhang Y
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):432-444. PubMed ID: 30606966
[TBL] [Abstract][Full Text] [Related]
24. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease.
Grandi NC; Breitling LP; Vossen CY; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
Am Heart J; 2010 Jun; 159(6):1044-51. PubMed ID: 20569718
[TBL] [Abstract][Full Text] [Related]
25. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
26. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
Li M; Chen P; Li J; Chu R; Xie D; Wang H
J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
[TBL] [Abstract][Full Text] [Related]
27. Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma.
Shin DY; Kim S; Park S; Koh JS; Kim CH; Baek H; Yang SH; Na II
Endocr Relat Cancer; 2014 Oct; 21(5):715-21. PubMed ID: 25030993
[TBL] [Abstract][Full Text] [Related]
28. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
29. Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke.
Park KY; Chung PW; Kim YB; Moon HS; Suh BC; Won YS; Kim JM; Youn YC; Kwon OS
Cerebrovasc Dis; 2015; 40(1-2):73-80. PubMed ID: 26184826
[TBL] [Abstract][Full Text] [Related]
30. Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial.
Economos CD; Moore CE; Hyatt RR; Kuder J; Chen T; Meydani SN; Meydani M; Klein E; Biancuzzo RM; Holick MF
J Acad Nutr Diet; 2014 May; 114(5):709-17. PubMed ID: 24139824
[TBL] [Abstract][Full Text] [Related]
31. Widespread vitamin D deficiency in urban Massachusetts newborns and their mothers.
Merewood A; Mehta SD; Grossman X; Chen TC; Mathieu JS; Holick MF; Bauchner H
Pediatrics; 2010 Apr; 125(4):640-7. PubMed ID: 20308219
[TBL] [Abstract][Full Text] [Related]
32. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
33. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.
Savoie MB; Paciorek A; Zhang L; Van Blarigan EL; Sommovilla N; Abrams D; Atreya CE; Bergsland EK; Chern H; Kelley RK; Ko A; Laffan A; Sarin A; Varma MG; Venook AP; Van Loon K
J Gastrointest Cancer; 2019 Dec; 50(4):769-779. PubMed ID: 30058032
[TBL] [Abstract][Full Text] [Related]
35. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract][Full Text] [Related]
36. The risk of all-cause mortality is inversely related to serum 25(OH)D levels.
Saliba W; Barnett O; Rennert HS; Rennert G
J Clin Endocrinol Metab; 2012 Aug; 97(8):2792-8. PubMed ID: 22648653
[TBL] [Abstract][Full Text] [Related]
37. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
[TBL] [Abstract][Full Text] [Related]
38. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Eur J Cancer Prev; 2019 May; 28(3):203-211. PubMed ID: 29438161
[TBL] [Abstract][Full Text] [Related]
39. Association of Serum 25-Hydroxyvitamin D and Parathyroid Hormone With Hypertension in Middle-Aged and Older Korean Adults.
Kim D; Kim J
Am J Hypertens; 2016 Jan; 29(1):96-103. PubMed ID: 25907223
[TBL] [Abstract][Full Text] [Related]
40. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
